Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
3000 participants
OBSERVATIONAL
2017-11-26
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ischemic Stroke in Chinese Young Adults
NCT02756494
Cohort Study for Severe Ischaemic Stroke
NCT03222024
Chinese Atherosclerosis Risk Evaluation- Phase II
NCT02017756
Computer-based Online Database of Acute Stroke Patients for Stroke Management Quality Evaluation
NCT04487340
A Study on the Status of Nutritional Risk Screening and Nutritional Therapy in Neurology Hospitalized Stroke Patients
NCT05454397
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Young adult stroke patients
Young adult (18-45 years old) patients with confirmed first-ever acute ischemic stroke
Treatment following current guidelines
Treatment following current guidelines
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Treatment following current guidelines
Treatment following current guidelines
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* First-ever acute ischemic stroke
* Onset of symptoms within 72 hours of inclusion
* Willing to participate in follow-up visits
Exclusion Criteria
* Failure to give their informed consent
18 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jiujiang No.1 People's Hospital
OTHER
Dezhou People's Hospital
OTHER
The Affiliated Hospital of Yanbian University
OTHER
First Affilated Hospital of Jiamusi University
UNKNOWN
Xuchang Central Hospital
UNKNOWN
Inner Mongolia People's Hospital
OTHER
Shaoxing People's Hospital
OTHER
Chinese PLA General Hospital
OTHER
General Hospital of Ningxia Medical University
OTHER
General Hospital of Shenyang Military Region
OTHER
Siping Central People's Hospital
OTHER
The First Affilated Hospital of the Medical College, Shihezi University
UNKNOWN
Daqing Oilfieled General Hospital
UNKNOWN
Heilongjiang Provicial Hospital
UNKNOWN
The First Affiliated Hospital of Soochow University
OTHER
Luoyang Central Hospital Affilated to Zhengzhou University
UNKNOWN
Wuzhou Red Cross Hospital
OTHER
Cangzhou Central Hospital
OTHER
Binzhou Medical University
OTHER
Affilated Hospital of Inner Mongolia University for the Nationalities
UNKNOWN
Fudan University Pudong Medical Center
UNKNOWN
Yi Yang
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yi Yang
Associate dean, Director of Cerebrovascular Disease Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
First Hospital of Jilin University
Changchun, Jilin, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REACH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.